AK5 antisense RNA 1 (AK5-AS1)

AK5 antisense RNA 1 (AK5-AS1) is a noncoding antisense RNA believed to be transcribed from the locus opposite the AK5 gene. Antisense RNAs are transcripts that are complementary to sense (protein-coding) RNAs and are known to regulate gene expression at levels such as transcription, mRNA stability, and translation, sometimes through epigenetic modulation or by direct physical binding to their sense counterparts. Many antisense RNAs have been studied for their potential role in gene silencing, genomic imprinting, and disease pathogenesis, particularly in cancer. However, the specific biological functions, disease associations, and molecular mechanisms for AK5-AS1 remain to be established in peer-reviewed literature. There is no evidence that AK5-AS1 is itself a validated protein, therapeutic receptor, enzyme, transporter, or any typical druggable target. Based on the available data, AK5-AS1 is not a validated therapeutic target such as an enzyme, receptor, transporter, or well-recognized disease-modulating RNA. The provided literature and curated databases do not describe AK5-AS1 as a major clinical or research target, and there is no evidence for its use as a biomarker or for known drug interactions.

Other names

none established; the main known designation is AK5 antisense RNA 1 or AK5-AS1

Not applicable (drugs targeting this specific RNA are not reported)